Literature DB >> 6607144

Evidence for B cell activation in patients with active rheumatoid arthritis.

P Y Youinou, W L Irving, M Shipley, J Hayes, P M Lydyard.   

Abstract

Peripheral blood lymphocytes and in some cases synovial eluate cells from 51 patients with rheumatoid arthritis (RA), were analysed for the percentages of cells bearing surface light chains (total B cells), IgM and IgD. In addition, their capacity to form rosettes with mouse erythrocytes (mRFC)--a property of a B cell subpopulation--was determined. Activity of the disease was assessed by clinical and laboratory criteria and classified as very active, moderately active and inactive. Normal, age and sex matched individuals and a group of patients with a variety of other rheumatological disorders, were used as control populations. Although there was no significant difference in percentages of total B cells in any of the groups compared with normal controls, there was a small but significant increase in the ratio of cells bearing IgM to those bearing IgD in patients with very active disease. This was paralleled by a significant decrease in the mRFC in this disease activity group. Patients with inactive disease showed no change in their proportions of IgM:IgD, but did show a significant increase in mRFC. These results are discussed in terms of the presence of activated B cells in patients with very active RA.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6607144      PMCID: PMC1535776     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  Immunglobulin classes, subclasses and complexes of IgG rheumatoid factor in rheumatoid plasma cells.

Authors:  E Munthe; J B Natvig
Journal:  Clin Exp Immunol       Date:  1972-09       Impact factor: 4.330

3.  Formation of mouse or sheep red-blood-cell rosettes by lymphocytes from normal and leukaemic individuals.

Authors:  G Stathopoulos; E V Elliott
Journal:  Lancet       Date:  1974-04-06       Impact factor: 79.321

4.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

5.  Rosette formation with mouse erythrocytes defines a population of human B lymphocytes unresponsive to pokeweed mitogen.

Authors:  G Lucivero; A R Lawton; M D Cooper
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

6.  Characterization of B-cell leukemias: a tentative immunomorphological scheme.

Authors:  B Koziner; S Kempin; S Passe; T Gee; R A Good; B D Clarkson
Journal:  Blood       Date:  1980-11       Impact factor: 22.113

7.  Impaired antigen-specific suppressor cell activity in patients with rheumatoid arthritis.

Authors:  E C Keystone; D D Gladman; R Buchanan; D Cane; L Poplonski
Journal:  Arthritis Rheum       Date:  1980-11

8.  Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect.

Authors:  J M Depper; H G Bluestein; N J Zvaifler
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

9.  Immunoglobulin D as a lymphocyte receptor.

Authors:  D S Rowe; K Hug; L Forni; B Pernis
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

10.  In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects.

Authors:  L Slaughter; D A Carson; F C Jensen; T L Holbrook; J H Vaughan
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

View more
  8 in total

1.  Evidence for oligoclonal B cell expansion in the peripheral blood of patients with rheumatoid arthritis.

Authors:  D A Fox; B R Smith
Journal:  Ann Rheum Dis       Date:  1986-12       Impact factor: 19.103

2.  Expression of CD 21, CD 22, and the mouse erythrocyte receptor on peripheral B lymphocytes in rheumatoid arthritis.

Authors:  S Hildebrandt; I von der Heydt; P von Wichert
Journal:  Ann Rheum Dis       Date:  1988-07       Impact factor: 19.103

3.  CD5 positive B cells in patients with rheumatoid arthritis: phorbol ester mediated enhancement of detection.

Authors:  P Youinou; L Mackenzie; J Jouquan; P Le Goff; P M Lydyard
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

4.  Rheumatoid factor (RF) distribution in periodontal disease.

Authors:  J Thé; J L Ebersole
Journal:  J Clin Immunol       Date:  1991-05       Impact factor: 8.317

5.  VH usage and somatic hypermutation in peripheral blood B cells of patients with rheumatoid arthritis (RA).

Authors:  S C Huang; R Jiang; W O Hufnagle; D E Furst; K R Wilske; E C Milner
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

6.  The stimulation of IgM rheumatoid factor from human B lymphocytes by rheumatoid arthritis complement-activating immune complexes.

Authors:  M Lorber; D Samuel; P Amlot; G S Panayi
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

7.  Abnormal responses of rheumatoid arthritis lymphocytes to Epstein-Barr virus infection in vitro: evidence for multiple defects.

Authors:  W L Irving; P R Walker; P M Lydyard
Journal:  Ann Rheum Dis       Date:  1985-07       Impact factor: 19.103

Review 8.  Circadian Clock and Complement Immune System-Complementary Control of Physiology and Pathology?

Authors:  Pooja Shivshankar; Baharan Fekry; Kristin Eckel-Mahan; Rick A Wetsel
Journal:  Front Cell Infect Microbiol       Date:  2020-08-14       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.